Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Vankelecom, Hugo  [Clear All Filters]
2024
Qi J, Li X, Cao Y, Long Y, Lai J, Yao Y, Meng Y, Wang Y, Chen X-D, Vankelecom H, et al. Locationally activated PRP via an injectable dual-network hydrogel for endometrial regeneration. Biomaterials. 2024;309:122615.
Gilbert PM, Hofmann S, Ng H-H, Vankelecom H, Wells JM. Organoids in endocrine and metabolic research: current and emerging applications. Nat Rev Endocrinol. 2024.
Li X, Lin Y, Cheng X, Yao G, Yao J, Hu S, Zhu Q, Wang Y, Ding Y, Lu Y, et al. Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS. Hum Reprod Open. 2024;2024(2):hoae013.
2023
Hu S, Sun Z, Li B, Zhao H, Wang Y, Yao G, Li X, Bian X, Li TChiu, Vankelecom H, et al. iTRAQ-based proteomic analysis unveils ACSL4 as a novel potential regulator of human endometrial receptivity. Endocrinology. 2023.
Laporte E, Vankelecom H. Organoid models of the pituitary gland in health and disease. Front Endocrinol (Lausanne). 2023;14:1233714.
Sun Y, Cui L, Lu Y, Tan J, Dong X, Ni T, Yan J, Guan Y, Hao G, Liu J-Y, et al. Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization: A Randomized Clinical Trial. JAMA. 2023;329(17):1460-1468.
Hennes A, Devroe J, De Clercq K, Ciprietti M, Held K, Luyten K, Van Ranst N, Maenhoudt N, Peeraer K, Vankelecom H, et al. Protease secretions by the invading blastocyst induce calcium oscillations in endometrial epithelial cells via the protease-activated receptor 2. Reprod Biol Endocrinol. 2023;21(1):37.
2021
Kagawa H, Javali A, Khoei HHeidari, Sommer TMaria, Sestini G, Novatchkova M, Reimer YScholte Op, Castel G, Bruneau A, Maenhoudt N, et al. Human blastoids model blastocyst development and implantation. Nature. 2021.
Stejskalová A, Vankelecom H, Sourouni M, Ho MY, Götte M, Almquist BD. In vitro modelling of the physiological and diseased female reproductive system. Acta Biomater. 2021.
Vennekens A, Laporte E, Hermans F, Cox B, Modave E, Janiszewski A, Nys C, Kobayashi H, Malengier-Devlies B, Chappell J, et al. Interleukin-6 is an activator of pituitary stem cells upon local damage, a competence quenched in the aging gland. Proc Natl Acad Sci U S A. 2021;118(25).
Nys C, Vankelecom H. Pituitary disease and recovery: how are stem cells involved?. Mol Cell Endocrinol. 2021:111176.
2020
Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, Hermans F, Arijs I, Cox B, Van Nieuwenhuysen E, et al. Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models. Stem Cell Reports. 2020.
2018
Zubeldia-Brenner L, De Winne C, Perrone S, Rodriguez-Segui SAndres, Willems C, Ornstein AMaria, Lacau-Mengido IMaria, Vankelecom H, Cristina C, Becú-Villalobos D. Inhibition of Notch signaling attenuates pituitary adenoma growth in nude mice. Endocr Relat Cancer. 2018.
2013
Wouters J, Stas M, Gremeaux L, Govaere O, Van den Broeck A, Maes H, Agostinis P, Roskams T, van den Oord JJ, Vankelecom H. The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis. PLoS One. 2013;8(10):e76550.
Van den Broeck A, Vankelecom H, Van Delm W, Gremeaux L, Wouters J, Allemeersch J, Govaere O, Roskams T, Topal B. Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One. 2013;8(9):e73968.